Journal ArticleOPEN ACCESS

How California Institute for Regenerative Medicine Research Programs Support Science and Regulatory Policy

  • Lomax G
  • DeWitt N
  • Millan M
  • et al.
Stem Cells Translational Medicine (2014) 3(6) 673-674
DOI: 10.5966/sctm.2014-0069
5Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The authors discuss the California Institute for Regenerative Medicine's focus on state, national, and international regulatory policy issues impacting basic research and translational medicine.

Cite

CITATION STYLE

APA

Lomax, G. P., DeWitt, N. D., Millan, M. T., & Feigal, E. G. (2014). How California Institute for Regenerative Medicine Research Programs Support Science and Regulatory Policy. Stem Cells Translational Medicine, 3(6), 673–674. https://doi.org/10.5966/sctm.2014-0069

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free